Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
2.
ANZ J Surg ; 93(9): 2086-2091, 2023 09.
Artigo em Inglês | MEDLINE | ID: mdl-37132128

RESUMO

BACKGROUND: Chronic intestinal pseudo-obstruction (CIPO) may be a primary or secondary phenomenon and is often multifactorial. Treatment is largely directed at improving colonic motility. The use of cholinesterase inhibitors such as pyridostigmine has been hypothesized to increase acetylcholine in the bowel, improving symptoms and transit times. METHODS: A systematic review of the use of pyridostigmine in CIPO was conducted using scientific and commercial search engines identifying scientific studies enrolling adult human subjects, published from 2000 to 2022 in the English language. RESULTS: Four studies were identified including two randomized controlled trials (RCT) and two observational studies. The studies had heterogenous inclusion criteria, dosing regimens and reported outcomes. Two studies were identified as being at high risk of bias. All studies reported improved patient outcomes with use of pyridostigmine, and low rates (4.3%) of mild cholinergic side effects. No major side effects were reported. CONCLUSION: The use of pyridostigmine in management of CIPO is biologically plausible due to its ability to increase colonic motility, and early studies on its role are uniformly suggestive of benefit with low side-effect profile. Four clinical studies have been conducted to date, with small sample sizes, heterogeneity and high risk of bias. Further high-quality studies are required to enable assessment of pyridostigmine's utility as an effective management strategy in CIPO.


Assuntos
Pseudo-Obstrução Intestinal , Brometo de Piridostigmina , Adulto , Humanos , Brometo de Piridostigmina/uso terapêutico , Brometo de Piridostigmina/farmacologia , Motilidade Gastrointestinal , Pseudo-Obstrução Intestinal/tratamento farmacológico , Pseudo-Obstrução Intestinal/diagnóstico , Inibidores da Colinesterase/uso terapêutico , Inibidores da Colinesterase/farmacologia , Doença Crônica
3.
Dis Colon Rectum ; 65(4): 546-551, 2022 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-34759239

RESUMO

BACKGROUND: Postoperative pain is common in hemorrhoidectomy patients. Local anesthetic given either as an intraoperative pudendal nerve block or as a local wound infiltration may help alleviate postoperative pain. OBJECTIVES: This study sought to determine whether the addition of an intraoperative pudendal nerve block to a perianal local wound infiltration and standardized analgesia regimen was superior to a perianal local wound infiltration and standardized analgesia regimen alone in reducing early postoperative pain following hemorrhoidectomy. The secondary objective was to measure differences between treatment groups in perceived perianal numbness, oral opioid requirements, and adverse events. DESIGN: This study was a prospective, single-blinded randomized controlled trial approved by the Eastern Health Human Research and Ethics Committee in Melbourne, Australia (registration number: E09/2014). SETTINGS: Patients were recruited across 3 Australian hospitals. PATIENTS: Eighty patients with symptomatic hemorrhoids requiring hemorrhoidectomy in colorectal surgical outpatient clinics were successfully recruited and enrolled in the study, with 1 patient later dropping out. INTERVENTION: Patients were randomly assigned to either the pudendal nerve block group or a control group. The pudendal nerve block group received 5 mL bupivacaine 0.5% with adrenaline 1:200,000 to both pudendal nerve trunks bilaterally. Both groups received 10 mL of the same local anesthetic injected into the post-hemorrhoidectomy wound bed. MAIN OUTCOME MEASURES: Visual analogue scales were used to record patient pain scores. Dichotomous (yes/no) answers were recorded for secondary objectives. RESULTS: There were no significant differences in postoperative pain between groups at 4 hours, 8 hours, 12 hours, or 24 hours. Additionally, there were no significant differences between groups with respect to perceived perianal numbness, oral opioid usage or adverse events. LIMITATIONS: The authors recognize that without a nerve stimulator, an argument can be made that the pudendal nerve block was not actually achieved. CONCLUSION: Pudendal nerve block does not appear to demonstrate additional benefit in post-hemorrhoidectomy pain reduction beyond local anesthetic to the wound. See Video Abstract at http://links.lww.com/DCR/B780. BLOQUEO DEL NERVIO PUDENDO PARA EL DOLOR POSHEMORROIDECTOMA ESTUDIO PROSPECTIVO, ALEATORIO, CONTROLADO, CIEGO: ANTECEDENTES:El dolor posoperatorio es común en pacientes luego de una hemorroidectomía. La administración de anestésico local como bloqueo del nervio pudendo intraoperatorio o infiltración local de la herida puede ayudar a aliviar el dolor posoperatorio.OBJETIVOS:Determinar si agregar un bloqueo intraoperatorio del nervio pudendo a una infiltración local perianal de la herida y un régimen de analgesia estandarizado fue superior a una infiltración local perianal de la herida más un régimen de analgesia estandarizado para reducir el dolor posoperatorio precoz después de una hemorroidectomía. Los objetivos secundarios incluyeron sensación de adormecimiento perianal, requerimientos de opioides orales y eventos adversos informados.DISEÑO:Este estudio fue un ensayo controlado aleatorio, prospectivo, ciego, aprobado por el Comité de Ética e Investigación en Humanos de Eastern Health en Melbourne, Australia (número de registro: E09 / 2014).ESCENARIO:Los pacientes fueron reclutados en tres hospitales australianos.PACIENTES:Ochenta pacientes se inscribieron con éxito en el estudio, y más tarde un paciente abandonó.INTERVENCIÓN:Los pacientes fueron asignados al azar al grupo de bloqueo del nervio pudendo o al grupo control. El grupo de bloqueo del nervio pudendo recibió 5 ml de bupivacaína al 0,5% con adrenalina 1: 200.000 en ambos troncos del nervio pudendo bilateralmente. Ambos grupos recibieron 10 ml del mismo anestésico local inyectado en el lecho de la herida posterior a la hemorroidectomía.PRINCIPALES VARIABLES ANALIZADAS:Se utilizaron escalas analógicas visuales para registrar las puntuaciones de dolor del paciente. Se registraron respuestas dicotómicas (sí / no) para los objetivos secundarios.RESULTADOS:No hubo diferencias significativas en el dolor posoperatorio entre los grupos a las 4, 8, 12 o 24 horas. Además, no hubo diferencias significativas entre los grupos con respecto al adromecimiento perianal percibido, el uso de opioides orales o los eventos adversos.LIMITACIONES:Sin el uso de un estimulador nervioso, se puede argumentar que el bloqueo del nervio pudendo no se logró realmente.CONCLUSIÓNES:El bloqueo del nervio pudendo no parece demostrar un beneficio adicional en la reducción del dolor posterior a la hemorroidectomía más allá del anestésico local en la herida. Consulte Video Resumen en http://links.lww.com/DCR/B780.


Assuntos
Analgésicos Opioides , Nervo Pudendo , Analgésicos Opioides/uso terapêutico , Anestésicos Locais , Austrália , Bupivacaína , Humanos , Hipestesia , Dor Pós-Operatória/tratamento farmacológico , Dor Pós-Operatória/prevenção & controle , Estudos Prospectivos
4.
ANZ J Surg ; 88(4): 278-283, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29124893

RESUMO

Ischaemic colitis is the most common form of gastrointestinal ischaemia, but may be confused with acute mesenteric ischaemia, inflammatory bowel disease or infectious colitis. This review article outlines the current classification, epidemiology and risk factors, as well as approaches about diagnosis and management to guide clinical practice. It also identifies areas for further research.


Assuntos
Colite Isquêmica/patologia , Colite/patologia , Colo/patologia , Isquemia/patologia , Colite Isquêmica/classificação , Colite Isquêmica/diagnóstico , Colite Isquêmica/epidemiologia , Colo/irrigação sanguínea , Tratamento Conservador/normas , Endoscopia do Sistema Digestório/métodos , Endoscopia do Sistema Digestório/normas , Feminino , Humanos , Masculino , Guias de Prática Clínica como Assunto , Fatores de Risco , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA